Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies

AIDS Research and Human Retroviruses

Volumn 15, Issue 2, 1999, Pages 149-159

  Golding, Hana ^a,d   Ouyang, Jun ^b   Zaitseva, Marina ^a   Broder, Christopher C ^c   Dimitrov, Dimiter S ^b   Lapham, Cheryl ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; OKT 4;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DENSITOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CELL LINE; EPITOPES; FLOW CYTOMETRY; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; JURKAT CELLS; PRECIPITIN TESTS; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 0033585415     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311574     Document Type: Article

References (30)

1. Allan JS: Receptor mediated activation of immunodeficiency viruses in viral fusion. Science 1991;252:1332-1323.
2. Sattentau QJ and Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991;174:407-415.
3. Szabo G, Pine PS, Weaver JL, Rao PE, and Aszalos A: CD4 changes conformation upon ligand binding. J Immunol 1992; 149:3596-3604.
4. Sattentau QJ, Moore JP, Vigraux F, Traincard F, and Poignard P: Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J Virol 1993;67:7383-7393.
5. Dimitrov SD and Broder CC: HIV receptors. In: HIV and Membrane Receptors. Landes Biosciences, Austin, Texas, 1997, pp. 61-74.
6. Moore JP, Yoshiyama H, Ho DD, Robinson J, and Sodroski J: Antigenie variation in gp120s from molecular clones of HIV LAI. AIDS Res Hum Retroviruses 1993;9:1185-1193.
7. Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, and Sodroski J: Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993;67:3978-3988.
8. Golding H, Dimitrov DS, Manischewitz J, Broder CC, Robinson J, Fabian S, Littman DR, and Lapham CK: Phorbol ester-induced downmodulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J Virol 1995;69:6140-6148.
9. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, and Sodroski J: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (London) 1996;384: 179-183.
10. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WH, and Sodroski J: A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998;280:1949-1953.
11. Lee S, Peden K, Dimitrov SD, Broder CC, Manischewitz J, Denisova G, Gershoni JM, and Golding H: Enhancement of human immunodeficiency virus 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody. J Virol 1997;71:6037-6043.
12. Gershoni JM, Denisova G, Raviv D, Smorodinsky NI, and Buyaner D: HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J 1993;7:1185-1187.
13. Denisova G, Raviv D, Mondor I, Sattentau QJ, and Gershoni JM: Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120. J Immunol 1997;158:1157-1164.
14. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, and Golding H: Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 1996;274:602-605.
15. Zaitseva M, Blauvelt A, Lee S, Lapham CK, Klaus-Kovtun V, Mostowski H, Manischewitz J, and Golding H: Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nature Med 1997;3:1369-1375.
16. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. J Exp Med 1997;185:1681-1691.
17. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, and Vance PJ: CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996;87:745-756.
18. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV entry cofactor: Functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
19. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
20. Hillman K, Shapira-Nahor O, Gruber MF, Hooley J, Manischewitz J, Seeman R, Vujcic L, Geyer SL, and Golding H: Chemically induced CD4 mutants of human T cell line. Evidence for dissociation between binding of HIV envelope and susceptibility to HIV infection and syncytia formation. J Immunol 1990;144:2131-2139.
21. Golding H, Manischewitz J, Vujcic L, Blumenthal R, and Dimitrov DS: The phorbol ester PMA inhibits HIV-envelope mediated fusion by modulating accessory component(s) in the CD4-expressing cells. J Virol 1994;68:1962-1969.
22. Signoret N, Oldridge J, Pelchen-Matthews A, Klasse PJ, Tran T, Brass LF, Rosenkilde MM, Schwartz TW, Holmes W, Dallas W, Luther MA, Wells TNC, Hoxie JA, and Marsh M: Phorbol ester and SDF-1 induce rapid endocytosis and downmodulation of the chemokine receptor CXCR4. J Cell Biol 1997;139:651-664.
23. DeVico AL, Rahman R, Welch J, Crowley R, Lusso P, Samgadharan MG, and Pal R: Monoclonal antibodies raised against covalently cross-linked complex of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp120. Virology 1995;211:583-588.
24. Celada F, Cambiaggi C, Maccari C, Burastero S, Gregory T, Patzer E, Porter J, McDanal C, and Matthews T: Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J Exp Med 1990;172:1143-1150.
25. Camerini D and Seed B: CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 1990;60:747-754.
26. Lifson JD, Hwang KM, Nava PL, Fraser B, Padgett M, Dunlop NM, and Eiden LE: Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science 1988;241:712-716.
27. Shapira-Nahor O, Golding H, Vujcic LK, Resot-Ruiz S, Fields RL, and Robey F: CD4-derived synthetic peptide blocks the binding of HIV-1 gp120 to CD4-bearing cells and prevents HIV-1 infection. Cell Immunol 1990;128:101-117.
28. Border CC and Berger EA: CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J Virol 1993;67(2):913-926.
29. Simon JH, Stumbles P, Signoret N, Somoza C, Pukavec M, Sattentau QJ, Barclay AN, and James W: Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1. J Virol 1997;71(2):1476-1484.
30. Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, and Devaux C: Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol 1993;150(1):290-301.